Nanobiotix (NBTX) announced the execution of another step in its financial strategy through the amendment of the company’s global licensing ...

Janssen has entered into a collaboration agreement with Phenex Pharmaceuticals AG, a German drug discovery company that focuses on developing innovative small molecule therapeutics, in the fields ...

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...

Speciality pharmaceutical group Essential Pharma has concluded the acquisition of Reminyl oral capsules from the Johnson & Johnson company, Janssen Pharmaceutica. The strategic move enhances ...

Janssen Pharmaceuticals, a subsidiary of Johnson &amp, Johnson, has signed an exclusive license agreement and entered into a three-year research and development collaboration with Swiss-company ...

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

A better understanding of early childhood microbiome shifts offers a unique window for detecting disease risk and intervening appropriately. In this webinar, Kevin J. Tracey and Lawrence Steinman will ...

The fellow is expected to actively participate in cutting-edge clinical pharmaceutical development programs at Janssen Research & Development, the pharmaceutical company of Johnson & Johnson. Our ...